BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22417846)

  • 1. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
    Stenzinger A; Wittschieber D; von Winterfeld M; Goeppert B; Kamphues C; Weichert W; Dietel M; Rabien A; Klauschen F
    Hum Pathol; 2012 Sep; 43(9):1471-81. PubMed ID: 22417846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
    Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
    Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
    Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancer.
    Stenzinger A; von Winterfeld M; Rabien A; Warth A; Kamphues C; Dietel M; Weichert W; Klauschen F; Wittschieber D
    Hum Pathol; 2012 Aug; 43(8):1314-21. PubMed ID: 22397871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z; Huang H; Li H; Chen W; Pan C
    J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3.
    Ueda K; Yamada K; Urashima M; Ishibashi Y; Shirai M; Nikaido T; Takahashi H; Okamoto A; Saito M; Yasuda M; Ohkawa K; Tanaka T
    Oncol Rep; 2007 Apr; 17(4):731-5. PubMed ID: 17342307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer.
    Zhong WD; Chen QB; Ye YK; Han ZD; Bi XC; Dai QS; Liang YX; Zeng GH; Wang YS; Zhu G; Chen ZN; He HC
    Cancer Epidemiol; 2010 Aug; 34(4):478-82. PubMed ID: 20483678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
    Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
    Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
    Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
    Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
    Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
    Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
    Tan H; Ye K; Wang Z; Tang H
    Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival stratification panel of colorectal carcinoma with combined expression of carcinoembryonic antigen, matrix metalloproteinases-2, and p27 kip1.
    Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
    Dis Colon Rectum; 2007 Nov; 50(11):1887-98. PubMed ID: 17882488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic significance of fascin, extracellular matrix metalloproteinase inducer, and ezrin expressions in colorectal adenocarcinoma.
    Jung EJ; Lee JH; Min BW; Kim YS; Choi JS
    Indian J Pathol Microbiol; 2011; 54(1):32-6. PubMed ID: 21393873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.